The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Inflammatory Mechanisms and Oxidative Stress as Key Factors Responsible for Progression of Neurodegeneration: Role of Brain Innate Immune System
Abstract
Chronic inflammation is characterized by longstanding microglial activation followed by sustained release of inflammatory mediators, which aid in enhanced nitrosative and oxidative stress. The sustained release of inflammatory mediators propels the inflammatory cycle by increased microglial activation, promoting their proliferation and thus stimulating enhanced release of inflammatory factors. Elevated levels of several cytokines and chronic neuroinflammation have been associated with many neurodegenerative disorders of central nervous system like age-related macular degeneration, Alzheimer disease, multiple sclerosis, Parkinson's disease, Huntington' disease, and tauopathies. This review highlights the basic mechanisms of neuroinflammation, the characteristics of neurodegenerative diseases, and the main immunologic responses in CNS neurodegenerative disorders. A comprehensive outline for the crucial role of microglia in neuroinflammation and neurodegeneration and the role of Toll-like receptor signalling in coexistence of inflammatory mechanisms and oxidative stress as major factors responsible for progression of neurodegeneration have also been presented.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Increased biomarkers of oxidative stress (Furman et al., 2016), inflammation and chronic neuroinflammation are reported to be associated with many neurodegenerative disorders of central nervous system (CNS) including AD (Leszek et al., 2016).”
From Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial (2016) · cites this paper as Leszek et al., 2016
Citations
Cites
The Classical Complement Cascade Mediates CNS Synapse Elimination
Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., Micheva, K. D., Mehalow, A. K., Huberman, A. D., Stafford, B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.036 · Cited by 3,313
Brain energy metabolism: focus on Astrocyte-neuron metabolic cooperation
Bélanger, M., Allaman, I., & Magistretti, P. J. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.016 · Cited by 2,313
Chronic inflammation and cytokines in the tumor microenvironment
Landskron, G., De la Fuente, M., Thuwajit, P., Thuwajit, C., & Hermoso, M. A. (2014) · Journal of Immunology Research · doi:10.1155/2014/149185 · Cited by 1,765
The roles of intracellular protein-degradation pathways in neurodegeneration
Rubinsztein, D. C. (2006) · Nature · doi:10.1038/nature05291 · Cited by 1,625
Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism
Block, M. L., & Hong, J.-S. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.06.004 · Cited by 1,557
Oxidative stress, mitochondrial damage and neurodegenerative diseases.
Guo, C., Sun, L., Chen, X., & Zhang, D. (2013) · PubMed · doi:10.3969/j.issn.1673-5374.2013.21.009 · Cited by 1,371
Oxidative stress and mitochondrial dysfunction in Alzheimer’s disease
Wang, X., Wang, W., Li, L., Perry, G., Lee, H.-G., & Zhu, X. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.10.015 · Cited by 1,357
Toll‐like Receptor and RIG‐1‐like Receptor Signaling
Kawai, T., & Akira, S. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1443.020 · Cited by 1,017
Regulation of innate immune responses in the brain
Rivest, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2565 · Cited by 843
Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits
Tang, S.-C., Arumugam, T. V., Xu, X., Cheng, A., Mughal, M. R., Jo, D. G., Lathia, J. D., Siler, D. A., Chigurupati, S., Ouyang, X., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702553104 · Cited by 779
Cited by
Sorted by citations
Items 101–200 of 206
Rastogi, S., & Haldar, C. (2019) · Journal of Thermal Biology · doi:10.1016/j.jtherbio.2019.102456 · Cited by 15
Neuroimmunoendocrinology of SARS-CoV-2 Infection
Bellastella, G., Cirillo, P., Carbone, C., Scappaticcio, L., Maio, A., Botta, G., Tomasuolo, M., Longo, M., Pontillo, A., Bellastella, A., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10112855 · Cited by 14
Kooshki, R., Abbasnejad, M., Esmaeili‐Mahani, S., Raoof, M., Aghtaei, M. M., & Dabiri, S. (2018) · The Korean journal of pain · doi:10.3344/kjp.2018.31.3.174 · Cited by 14
“which raise the risk of neural loss and deficiency [32].”
BackgroundOnaolapo, O. J., Olofinnade, A. T., Ojo, F. O., & Onaolapo, A. Y. (2021) · Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry · doi:10.2174/1871523021666220815151559 · Cited by 12
Munan, S., Mondal, A., Shailja, S., Pati, S., & Samanta, A. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.3c05981 · Cited by 13
Dolanbay, S. N., Şirin, S., & Aslım, B. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04520-x · Cited by 13
“Activation of microglia cells and the role of inflammatory mediators further exacerbate this cycle between oxidative stress and inflammation [4, 5].”
Chen, B., Li, W., Wang, G., Li, G., Liu, J.-Q., Zheng, J., Wang, Q., Li, H., Dai, S., & Huang, J. (2018) · PeerJ · doi:10.7717/peerj.4756 · Cited by 13
“((Leszek et al., 2016); (Wyss-Coray & Rogers, 2012), PLA2 (Gentile et al.”
Kooshki, R., Abbasnejad, M., Esmaeili‐Mahani, S., & Raoof, M. (2018) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20180099 · Cited by 13
Cyclic Peptides in Neurological Disorders: The Case of Cyclo(His-Pro)
Bellezza, I., Peirce, M. J., & Minelli, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814905-8.00010-1 · Cited by 13
“In fact, markers of oxidative stress and nitrosative stress are a defining feature of all neurodegenerative diseases and strongly corroborate a causal link between ROS/RNS and neurodegeneration (Gupta et al., 2014; Leszek et al., 2016; Tsang and Chung, 2009; Valko et al., 2007) .”
BackgroundAkpinar, G. G., Adıgüzel, E., Gungor, B., Kahraman, T., Gürsel, M., Yılmaz, B., & Gürsel, İ. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171003 · Cited by 13
Zhao, H., Li, S., He, L., et al. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02633-1 · Cited by 12
Complement factor B is essential for the proper function of the peripheral auditory system
Brown, L. N., Barth, J. L., Jafri, S. H., Rumschlag, J. A., Jenkins, T. R., Atkinson, C., & Lang, H. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1214408 · Cited by 12
Li, L., zhao, Y., Ding, Y., Guo, L., Dai, R., Chen, A., & Duan, G. (2025) · Scientific Reports · doi:10.1038/s41598-025-87182-6 · Cited by 12
Chronic Neuroplasticity Changes Following Neurotropic Viral Infection: Mechanisms and Implications
Mohabbat, A., & Baghi, H. B. (2025) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01622-5 · Cited by 12
“Afterward, oxidative stress causes lipid, protein, and genetic structural alterations that result in the degeneration of nerves (Leszek et al. 2016).”
Neural stem cells fate under neuroinflammatory conditions and oxidative stress response
Torrisi, F., Denaro, S., Ragonese, J., D’Aprile, S., Zappalà, A., & Parenti, R. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1736865 · Cited by 12
“…Frontiers in Cellular Neuroscience 02 frontiersin.org complex and persistent immune response, where inflammatory mediators and prolonged reactive phenotypes of microglia and astrocytes give rise to oxidative stress within the neural microenvironment (Leszek et al., 2016; Russo et al., 2022).”
Hippocampal Astrocyte Response to Melatonin Following Neural Damage Induction in Rats
Babaee, A., Eftekhar‐Vaghefi, S. H., Soltani, S. D., Asadi‐Shekaari, M., Shahrokhi, N., & Basiri, M. (2021) · Basic and Clinical Neuroscience Journal · doi:10.32598/bcn.12.2.986.1 · Cited by 11
“stresses (Leszek et al., 2016), we investigate effects of exogenous administration of melatonin on astrocyte activation induced by traumatic brain injury in rat hippocampus and”
BackgroundNoss, M. M., Millwood, S. N., & Kuhlman, K. R. (2022) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100465 · Cited by 10
López‐González, I., Cordomí, C. T., & Ferrer, I. (2017) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw117 · Cited by 10
“Although little is known about the causes of glial activation in normal aging (39), oxidative stress can mediate inflammation (29, 40), and microglia and astrocytes are sensitive to oxidative stress (41, 42).”
BackgroundUnraveling the intricate link between cell death and neuroinflammation using Drosophila as a model
Rai, P., & Bergmann, A. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1479864 · Cited by 9
Li, C., Chen, G., Wang, J., et al. (2024) · Molecular Medicine · doi:10.1186/s10020-024-01055-8 · Cited by 8
“Oxidative stress and chronic inflammation are now recognized as significant factors in the development of DN (Leszek et al. 2016).”
Han, B., Luo, J., & Xu, B. (2023) · Nutrients · doi:10.3390/nu15184030 · Cited by 8
Thellung, S., Gatta, E., Pellistri, F., Villa, V., Corsaro, A., Nizzari, M., Robello, M., & Florio, T. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9749-2 · Cited by 8
Go, M. J., Kim, J. M., Lee, H. L., Kim, T. Y., Joo, S. G., Kim, J. H., Lee, H. S., Kim, D., & Heo, H. J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814084 · Cited by 8
Wang, W., Wu, H., Li, J., Chen, Z., Liu, J., Xu, E., Hassanin, A. A., Rahman, S. U., Chen, L., & Zheng, R. (2025) · PROTOPLASMA · doi:10.1007/s00709-025-02075-9 · Cited by 7
“Additionally, ROS metabolites generated by oxidative stress in intestinal cells can activate NF-κB, triggering or amplifying inflammatory responses and leading to the production of various cytokines (Leszek et al. 2016).”
Targeting phosphodiesterase 4 as a potential therapy for Parkinson’s disease: a review
Nongthombam, P. D., & Haobam, R. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09484-8 · Cited by 7
Kegler, A., Pascotini, E. T., Caprara, A. L. F., et al. (2021) · Epileptic Disorders · doi:10.1684/epd.2021.1236 · Cited by 7
Farooqui, T., & Farooqui, A. A. (2017) · Wiley eBooks · doi:10.1002/9781119155195.ch16 · Cited by 6
Pupyshev, A. B., Короленко, Т. А., & Tikhonova, M. A. (2023) · Neurochemical Journal · doi:10.1134/s1819712423040190 · Cited by 6
Pathophysiological Mechanisms of Huntington’s Disease
Ignácio, Z. M., Quevedo, J., & Réus, G. Z. (2018) · Springer eBooks · doi:10.1007/978-981-13-0944-1_5 · Cited by 6
Sanchís-Soler, G., Tortosa‐Martínez, J., Manchado, C., & Cortell-Tormo, J. M. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.01.002 · Cited by 6
Lipopolysaccharide (LPS) induces increased epidermal green autofluorescence of mousePreprint
Li, Y., Zhang, M., Tao, Y., & Ying, W. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/501189 · Cited by 6
Deng, L., Luo, Q., Liu, Y., Wang, Y., Xiong, Z., Wang, H., Zhao, L., Jia, L., Shi, R., Huang, C., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1506944 · Cited by 6
Elhag, M., Ahmad, M. N., El‐Atawy, M. A., Alharbi, H. Y., Aljohani, M. S., Alrashdi, S., Omar, A. Z., & El-Rahman, M. A. (2025) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2025.128477 · Cited by 5
Phytoactive drugs used in the treatment of Alzheimer’s disease and dementia
Soni, A. G., Verma, A., Joshi, R., Shah, K., Soni, D., Kaur, C. D., Saraf, S., & Chauhan, N. S. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03243-z · Cited by 5
“Inflammation and oxidative stress Chronic inflammation and oxidative stress are observed in the brains of individuals with AD (Leszek et al. 2016).”
Binesh, A., Venkatachalam, K., & Ramachandran, S. (2024) · The Natural Products Journal · doi:10.2174/0122103155294834240607054701 · Cited by 5
Telmisartan attenuates hydrogen peroxide-induced apoptosis in differentiated PC12 cells
Du, G. T., Ke, X., Meng, G., Liu, G. J., Wu, H., Gong, J., Qian, X. D., Cheng, J. L., & Hong, H. (2018) · Metabolic Brain Disease · doi:10.1007/s11011-018-0237-z · Cited by 5
Immunosenescence and Alzheimer’s Disease
Fülöp, T., Larbi, A., Khalil, A., Plotka, A., Laurent, B., Ramassamy, C., Bosco, N., Hirokawa, K., Frost, E. H., & Witkowski, J. M. (2021) · Healthy ageing and longevity · doi:10.1007/978-3-030-87532-9_9 · Cited by 4
Modulation of Innate Immune Memory Dynamics by Subcellular Reactive Oxygen Species
Geng, S., Lin, R., Wu, Y., Wang, J., & Li, L. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0304 · Cited by 5
“The unbalanced redox status, due to altered peroxisomal biogenesis and decreased catalase activity, can collectively lead to oxidative stress, in turn contributing to various aspects of chronic inflammatory diseases (Leszek et al., 2016).”
Psychobiotics: a new way in psychopharmacology, or How do bacteria manage our brain?
Andreeva, I. V., Tolpygo, A. V., Andreev, V. А., Azyzov, I. S., Golman, I. A., Osipova, N. N., Privolnev, V. V., Stetsiouk, О. U., & Sokolovskaya, V. V. (2022) · Clinical Microbiology and Antimicrobial Chemotherapy · doi:10.36488/cmac.2022.2.108-133 · Cited by 5
Pezeshki-Nia, S., Asle‐Rousta, M., & Mahmazi, S. (2020) · Europe PMC (PubMed Central) · doi:10.34171/mjiri.34.10 · Cited by 4
“Pervasive studies have shown reciprocal impacts of oxidative stress and inflammation pathways (35).”
BackgroundRéus, G. Z., Abelaira, H. M., Coutellier, L. D., Manosso, L. M., & Pavlovic, Z. M. (2022) · Springer eBooks · doi:10.1007/978-3-030-87480-3_3 · Cited by 4
Ahmad, S., Shahab, U., Ashraf, J. M., Alyahyawi, A., Ansari, M. A., Fatma, S., Alshammari, A. M., Akasha, R., Asiri, S. M., Puri, P., et al. (2025) · Frontiers in Nanotechnology · doi:10.3389/fnano.2025.1564954 · Cited by 3
Kushawaha, S. K., Vashisht, K., Kumar, H., Ashawat, M. S., & Baldi, A. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01981-x · Cited by 3
Oh, T. W., Ban, Y., & Kang, Y. (2024) · Applied Biological Chemistry · doi:10.1186/s13765-024-00928-0 · Cited by 3
“MAPKs are involved in the production of neuroinflammatory regulators and regulate cell functions, including survival, death, and inflammation [30].”
BackgroundHaroon, H., Khan, Z., Javaid, W., & Xing, L. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47020087 · Cited by 3
Elucidating the potential of natural bioactive compounds in neuroprotection
Debnath, A., Majumder, R., Singh, M. K., Saha, R. P., & Das, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95735-9.00032-2 · Cited by 3
Zhang, Y., Glukhov, E., Yu, H., Gerwick, L. G., Dorrestein, P. C., & Gerwick, W. H. (2020) · ChemRxiv · doi:10.26434/chemrxiv.12760352 · Cited by 3
Munan, S., Mondal, A., Singh, S., Pati, S., & Samanta, A. (2023) · ChemRxiv · doi:10.26434/chemrxiv-2023-vk4f4 · Cited by 3
Ayurveda: Ayurvedic herbs against neurological disorders: are they golden nuggets?
Muralidhara, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-19084-1.00022-3 · Cited by 2
Li, Y., Zhou, L., Xia, Q., et al. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106532 · Cited by 2
Akomolafe, S. F., Oriyomi, I. A., Akintoye, O. O., Ajayi, O. O., Ojo, O. O., Ajayi, O. B., Oyetayo, F. L., & Asogwa, N. T. (2025) · Discover Food · doi:10.1007/s44187-025-00612-2 · Cited by 2
“It can also induce brain inflammation, damaging neurons and impairing brain function [68, 69].”
Yang, J., Chen, S., Xing, P., Hu, D., Liu, K., Ye, Z., Xia, J., He, J., Qian, Y., & Wu, T. (2026) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2026.112005 · Cited by 2
Oxidative Stress and Neurodegeneration
Osafo, N., Obiri, D. D., Danquah, K. O., Yeboah, K. O., Antwi, A. O., & Oppong, M. B. (2018) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-5225-5282-6.ch002 · Cited by 2
Shemery, A., Gibson, M., Gorrell, E., Daniel, D., Piontkivska, H., & Novak, C. M. (2025) · F1000Research · doi:10.12688/f1000research.152034.2 · Cited by 2
“Brain oxygen consumption is high, making it vulnerable to oxidative stress which can trigger inflammation (Leszek et al., 2016).”
Yang, F., Zhou, L., Deng, J., Wang, Y., Yang, Z., Zhang, Y., Liu, Y., & Zhang, Y. (2025) · Journal of Oceanology and Limnology · doi:10.1007/s00343-025-4317-8 · Cited by 2
“For example, Aβ deposition and neuroinflammation can activate microglia, triggering the release of pro-inflammatory cytokines and reactive oxygen species that damage neurons and astrocytes (Uttara et al., 2009; Leszek et al., 2016).”
Research Progress of Microglia Related Role in Alzheimer’s Disease
张, 倩. (2021) · Advances in Clinical Medicine · doi:10.12677/acm.2021.1112901 · Cited by 2
Pezeshki-Nia, S., Asle‐Rousta, M., & Mahmazi, S. (2020) · Medical Journal of the Islamic Republic of Iran · doi:10.47176/mjiri.34.10 · Cited by 2
Teng, Y., Gao, J., Tan, T., Zhang, X., Wang, Y., Zhang, J., & Ni, L. (2024) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2024.102390 · Cited by 2
Importance of Traditional Medicines in the Treatment of Neurological Diseases
Haobam, R., Nongthombam, P. D., & Tongbram, Y. C. (2024) · Interdisciplinary biotechnological advances · doi:10.1007/978-981-97-4600-2_20 · Cited by 1
Tripathi, S., Sharma, Y., & Kumar, D. (2025) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273370166250610152453 · Cited by 1
dos Santos, A. T., Carretero, V. J., Campano, J. H., de Pascual, R., Xu, N., Lee, S. M., Wong, C. T. T., Rádis‐Baptista, G., & Hernández-Guijo, J. M. (2025) · Pharmaceuticals · doi:10.3390/ph18111701 · Cited by 1
“Besides ion channel dysfunction, molecular alterations that contribute to the progression of neurodegenerative disease include inflammation and oxidative stress [22].”
Wang, K., Sun, Z., Wang, J., Diao, Z., Shen, D., Huang, X., & Shijun, Q. (2025) · European journal of medical research · doi:10.1186/s40001-025-03606-z · Cited by 1
“Persistent disruption of the central nervous system (CNS) microenvironment has been recognized as a core mechanism underlying various neurodegenerative diseases, chronic inflammation, and cognitive disorders [60, 61].”
Inflammatory proteins and cognitive decline in older Black adults
Meir, A. Y., Adeola, H. A., Tasaki, S., Liang, L., Robinson, R. A. S., Capuano, A. W., & Barnes, L. L. (2026) · Brain · doi:10.1093/brain/awag246 · Cited by 1
The auditory nerve glial transition zone is a focal site of age-related immune-myelin interactions
Payne, S. A., Anderson, H. R., Brown, I. M., Chai, J., Chen, P., Yao, H., Barth, J. L., & Lang, H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1757234 · Cited by 1
Hassanzadeh‐Taheri, M., Hayati, S., Mohammadifard, M., & Hosseini, M. (2021) · Pharmaceutical Sciences · doi:10.34172/ps.2021.61 · Cited by 1
“During the early and late phases of AD physiopathology, producing reactive oxygen species and nitrogen intermediates such as nitric oxides (NO) and peroxynitrite can cause neuronal damages.(12) Therefore, treatments with antioxidants such as vitamin E, minocycline, and resveratrol (RV) could protect neurons from OS/NS…”
BackgroundSala‐Jarque, J., García-Lara, E., Carreras-Dominguez, P., Zhou, C., Rabaneda‐Lombarte, N., Solà, C., Vidal-Taboada, J. M., Feiler, A. A., Abrahamsson, N., Kozlova, E. N., et al. (2022) · Nanomedicine · doi:10.2217/nnm-2022-0026 · Cited by 1
The role of astrocytes response triggered by hyperglycaemia during spinal cord injury
Sámano, C., & Mazzone, G. L. (2023) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2023.2264538 · Cited by 2
“…(Kimelberg and Nedergaard 2010, lawrence et al. 2023), along with glial scar formation and dysregulation of excitatory amino acids (lau and Yu 2001, leszek et al. 2016). the lack of AtP is another serious consequence related to the mechanisms of ROS-induced glutamate uptake blockade in astrocytes…”
An Investigation of the Inflammatory Landscape in the Brain and Bone Marrow of the APP/PS1 Mouse
Chittimalli, K., Adkins, S., Arora, S., Singh, J., & Jarajapu, Y. P. R. (2024) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-240024 · Cited by 1
Yaseen, A. A., Alzoubi, K. H., Al‐Sawalha, N. A., et al. (2024) · NeuroToxicology · doi:10.1016/j.neuro.2024.10.014 · Cited by 1
Nuñez-Musa, R. A., Sellés, A. J. N., Rossi, W. M., Marmolejos, R. G., & Martı́nez-Sánchez, G. (2019) · Ciencia y Salud · doi:10.22206/cysa.2019.v3i2.pp17-33 · Cited by 1
Zhang, Y., Glukhov, E., Yu, H., Gerwick, L. G., Dorrestein, P. C., & Gerwick, W. H. (2020) · ChemRxiv · doi:10.26434/chemrxiv.12760352.v1 · Cited by 1
“…as Alzheimer’s disease and Parkinson’s disease, metabolic disorders like obesity, diabetes and cardiovascular diseases, as well as others (Alfadda and Sallam, 2012; Franceschi and Campisi, 2014; Leszek et al., 2016; McBean et al., 2017; Rani et al., 2016; Reuter et al., 2010; Siti et al., 2015).”
BackgroundNie, Y., Yang, J., Liang, J., Yang, Z., Zhou, L., Liu, Y., Ma, X., Qian, Z., Hong, P., Kalueff, A. V., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-685780/v1 · Cited by 1
Hippocampal Astrocyte Response to Melatonin Following Neural Damage Induction in Rat
Babaee, A., Eftekhar‐Vaghefi, S. H., Asadi‐Shekaari, M., Shahrokhi, N., Dehghani-Soltani, S., & Basiri, M. (2019) · Basic and Clinical Neuroscience Journal · doi:10.32598/bcn.9.10.415
Efecto protector de la tibolona en un modelo inflamatorio de microglía estimulado por palmitato
Hidalgo‐Lanussa, O. (2020) · Repositorio Institucional (Pontificia Universidad Javeriana) · doi:10.11144/javeriana.10554.38564
López‐Cerdán, A., Andreu, Z., Hidalgo, M. R., Grillo-Risco, R., Català-Senent, J. F., Soler-Sáez, I., Neva-Alejo, A., Gordillo, F., de la Iglesia-Vayá, M., & Garcia‐García, F. (2022) · Research Square · doi:10.21203/rs.3.rs-2058256/v1
Pupyshev, A. B., Короленко, Т. А., & Tikhonova, M. A. (2023) · Нейрохимия · doi:10.31857/s1027813323040192
Shemery, A., Gibson, M., Gorrell, E., Daniel, D., Piontkivska, H., & Novak, C. M. (2024) · F1000Research · doi:10.12688/f1000research.152034.1
Cao, W., Guo, J., Zhang, N., et al. (2024) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2024.11.002
“5,15,16 The pathological results of our study revealed that SWHQP significantly reduced brain tissue inflammation and the brain water content after intervention; moreover, SWHQP had a good antihypoxic effect on HHBI.”
Deng, J., Li, J., Azhar, M., et al. (2024) · Food, Nutrition and Health. · doi:10.1007/s44403-024-00008-7
Yordanov, Y., Tzankova, V., Stefanova, D., Georgieva, M., & Tzankova, D. (2025) · Antioxidants · doi:10.3390/antiox14050566
Ozone-induced Neurotoxicity: Mechanistic Insights and Implications for Neurodegenerative Diseases
Bjørklund, G., Gurgas, L., & Hangan, T. (2025) · Current Medicinal Chemistry · doi:10.2174/0109298673375058250624070823
Bilge, S., & Bilgin, H. (2025) · The European Research Journal · doi:10.18621/eurj.1745159
Hypothesis-Driven Insights and Clinical Trial Updates in Alzheimer’s Disease Pathogenesis
Alhawarri, M. B. (2025) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273387383250924031644
Haidary, M., Ansari, M., Ansari, S., Rezayee, H., Hanifi, S., & Hossaini, D. (2025) · Alcoholism Treatment Quarterly · doi:10.1080/07347324.2025.2603655
Kim, J., Lee, H.-J., Park, J.-H., Cha, B.-Y., & Hoe, H.-S. (2022) · Figshare · doi:10.6084/m9.figshare.20329567
Nie, Y., Yang, J., Zhou, L., Yang, Z., Liang, J., Liu, Y., Ma, X., Qian, Z., Hong, P., Kalueff, A. V., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19136068
Aykan, F. S., Saygın, D. A., Çölkesen, F., Poyraz, N., Evcen, R., Kılınç, M., Yıldız, E., Önalan, T., Akkuş, F. A., Çelik, E. E., et al. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15020503
“This phenomenon can be explained by more aggressive immune dysregulation, the cerebral effects of systemic inflammation, and neuroinflammatory processes associated with autoimmunity [51].”
Virus-induced changes in peroxisomal markers among HIV-infected patients
Butorov, E. V. (2026) · RUDN Journal of Medicine · doi:10.22363/2313-0245-2025-30-1-124-138
Translational evidence for increased central amygdala IL-6 activity in alcohol dependence
Onge, C. M. S., Erikson, C. M., Cruz, B., Borgonetti, V., Hashimoto, J. G., Cucinello‐Ragland, J. A., Fitzpatrick‐Schmidt, T., Rodriguez, L., Khom, S., Palmisano, M., et al. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03868-2 · Cited by 1
Padma, K. R., Don, K. R., Sankari, M., Harathi, K., & Sandhya, N. (2026) · Wiley eBooks · doi:10.1002/9781394360260.ch15
Nutritional Regulation of Neuro-Inflammation: Mechanisms, Evidence, and Public Health Benefits
Kumar, R., Aves, M., & Kaur, H. (2026) · Current Research in Nutrition and Food Science Journal · doi:10.12944/crnfsj.14.special-issue-june.03
Metadata
- Authors
- Leszek, J., E. Barreto, G., G|siorowski, K., Koutsouraki, E., Ávila-Rodrigues, M., & Aliev, G.
- Venue
- CNS & Neurological Disorders - Drug Targets
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2016-03-10
- Volume
- 15
- Issue
- 3
- Pages
- 329-336
- ISSN
- 1568-007X (ISSN-L)
- 1871-5273
- OpenAlex
- W2271123303
- Semantic Scholar
- 91475bee1cf3d32abe2d7e1be1755b559ca3dc93
- Cited by
- 206
- References
- 88
- Citations by year
- 2026: 13 · 2025: 19 · 2024: 23 · 2023: 16 · 2022: 13 · 2021: 23 · 2020: 20 · 2019: 16 · 2018: 31 · 2017: 23 · 2016: 9
- FWCI
- 14.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- CNS & Neurological Disorders - Drug Targets (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- neuroinflammation, neurodegeneration, microglial activation, oxidative stress, nitrosative stress, Toll-like receptor signaling, cytokines, Alzheimer's disease, Parkinson's disease, Huntington's disease, multiple sclerosis, age-related macular degeneration, tauopathy
- MeSH terms
- Animals, Brain, Humans, Immunity, Innate, Inflammation, Cytokines, Microglia, Oxidative Stress, Disease Progression, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review